HOXA7 promotes the metastasis of KRAS mutant colorectal cancer by regulating myeloid-derived suppressor cells

Table 1 Correlation between HOXA7 expression and clinicopathological characteristics in a cohort of human CRC

Clinicopathological variables	Tumor HOXA7 expression		P value
Clinicopathological variables	Negative (n = 203)	Positive (n = 159)	P value
Age
≤ 50	26	28	0.203
> 50	177	131
Gender
Female	88	73	0.626
Male	115	86
Tumor size (cm)
≤ 5	90	64	0.435
> 5	113	95
Tumor differentiation
Well or moderate	158	91	< 0.001
Poor	45	68
Tumor invasion
T1–T3	161	116	0.157
T4	69	103
Lymph node metastasis
Absent	177	117	0.001
Present	22	17
Distant metastasis
Absent	134	56	0.001
Present	69	103
TNM stage
I–II	131	59	< 0.001
III–IV	72	100
KRAS status
Wild	140	68	< 0.001
Mutation	63	91

ISSN: 1475-2867